MenHibrix (Hib-MenCY-TT)

BIOLOGICAL2 trials

Sponsors

GlaxoSmithKline

Conditions

Haemophilus Influenzae Type bNeisseria Meningitidis

Phase 2

Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines

CompletedNCT00134719

GlaxoSmithKlineHaemophilus Influenzae Type b, Neisseria Meningitidis

Start: 2005-04-11End: 2007-02-21Updated: 2018-07-19

Phase 3

Long-Term Antibody Persistence at 1, 3 and 5 Years After a Fourth Dose of GSK Biologicals' Hib-MenCY-TT Vaccine Compared to ActHIB

CompletedNCT00359983

GlaxoSmithKlineHaemophilus Influenzae Type b, Neisseria Meningitidis

Start: 2006-09-30End: 2011-05-31Updated: 2016-12-16

Related Papers

Immunogenicity and safety of measles-mumps-rubella and varicella vaccines coadministered with a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in toddlers: a pooled analysis of randomized trials.

2012-08-017 citations